iSpecimen Inc. Common Stock (ISPC) is a publicly traded Healthcare sector company. As of May 21, 2026, ISPC trades at $3.40 with a market cap of $5.17M and a P/E ratio of -0.39. ISPC moved -7.90% today. Year to date, ISPC is -71.09%; over the trailing twelve months it is -92.77%. Its 52-week range spans $3.20 to $332.00. Rallies surfaces ISPC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
iSpecimen Raises $2.5 Million in Private Placement at $5.12 per Share: iSpecimen has priced a $2.5 million private placement, issuing 488,281 shares at $5.12 each, with pre-funded warrants available at $5.1199 to accredited investors. Net proceeds will fund working capital, including up to $900,000 for marketing, with closing expected May 11 and share issuance capped at 19.99% pending shareholder approval.
| Metric | Value |
|---|---|
| Price | $3.40 |
| Market Cap | $5.17M |
| P/E Ratio | -0.39 |
| EPS | $-8.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $332.00 |
| 52-Week Low | $3.20 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.03M |
| Net Income | $-11.10M |
| Gross Margin | -24.98% |
ISPC analyst coverage data. Average price target: $0.00.